UUID:32233833-100F-4838-9771-EAEE5A35817A / C A , a , 5

TCGA-AR-AOUO—o1A-PR Redacted L , / .
mmmmummmmmmmmmmmmmmmmml Cawukwma;njhﬂmumn awafkmicbané
HWWWNMW WMMMWWMW sﬁﬂréuwﬁ NM (nay

 

| IN

Inmmmmmmmmmmmmmmmmmmml

Breast, left breast: simple mastectomy: Inﬁltrating ductal carcinoma, Nottingham grade III (of [11),
forming a 2.3 x 1.8 x 1.5 cm mass (AJCC pT2) situated in the lower inner quadrant at 2.0 cm from the
closest (inferior) margin. Vascular invasion is identiﬁed. The rest of the breast shows proliferative

ﬁbrocystic change with ductal hyperplasia of the usual type, apocrine metaplasia, and microcalciﬁcations.
Duct ectasia is also present. The nipple is unremarkable. Surgical margins are negative.

Lymph nodes, left axillary sentinel, excision: Multiple (2) left axillary sentinel lymph nodes each of them
showing one cluster of cells visible on cytokeratin immunohistochemistry stain only, but not on H&E
(size of micrometastasis is less than 0.2 mm) (blue dye present in both left axillary sentinel lymph nodes).

Lymph nodes, left axillary, excision: Multiple (2) left axillary lymph nodes are negative for tumor.

Estrogen: Negative, 0% nuclear staining
Progesterone: Negative, 0% nuclear Staining

ER (Estrogen Receptor) test was developed and its performance characteristics determined by ' '
It has not been cleared or approved by the Us. Food
and Drug Administration.

Seen in consultation with Drs. ' and

 
 
 
 
   

 
  
  

Drag-Mi: Discrepancv
Primary rumor Si '

. ._ re Discre an:
MPAA Discrepancy 3‘ V
PFIOI Ma'igmncy Hi

 

